Erratum: A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome
Molecular Autism volume 6, Article number: 31 (2015)
After the publication of , the authors noticed that a reference had been omitted from the text and reference list.
In the introduction and conclusion sections, there are references to using IGF-1 in human neuronal models of Phelan-McDermid syndrome. The correct reference for this study is:
Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Shu R, Sebastiano V, Krawisz A, Froehlich W, Bernstein JA, Hallmayer JF, Dolmetsch RE. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature. 2013 Nov 14;503(7475):267–71. doi: 10.1038/nature12618. Epub 2013 Oct 16. PubMed PMID: 24132240
Kolevzon A, Bush L, Wang AT, Halpern D, Frank Y, Grodberg D, et al. A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome. Mol Autism. 2014;5:54.
The online version of the original article can be found under doi:10.1186/2040-2392-5-54.
About this article
Cite this article
Kolevzon, A., Bush, L., Wang, A.T. et al. Erratum: A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome. Molecular Autism 6, 31 (2015). https://doi.org/10.1186/s13229-015-0025-0